{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:02Z","timestamp":1754161562071,"version":"3.41.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1017911918332","type":"journal-article","created":{"date-parts":[[2002,12,30]],"date-time":"2002-12-30T09:36:44Z","timestamp":1041241004000},"page":"556-561","source":"Crossref","is-referenced-by-count":4,"title":["Evidence for Prostaglandin-Producing Supressor Cells in HCV Patients with Normal ALT"],"prefix":"10.1007","volume":"47","author":[{"given":"Rui","family":"Marinho","sequence":"first","affiliation":[]},{"given":"Ruth","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Maria Livia","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Carneiro de Moura","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"369694_CR1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0168-8278(99)80154-8","volume":"30","author":"EASL","year":"1999","unstructured":"EASL: Consensus statement, EASL International Consensus Conference on Hepatitis C. J Hepatol 30:956\u2013961, 1999","journal-title":"J Hepatol"},{"key":"369694_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7326\/0003-4819-101-6-794","volume":"101","author":"JH Gilliam 3d","year":"1984","unstructured":"Gilliam JH 3d, Geisinger KR, Richter JE: Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis. Ann Intern Med 101:794\u2013795, 1984","journal-title":"Ann Intern Med"},{"key":"369694_CR3","first-page":"65","volume":"72","author":"WHO","year":"1997","unstructured":"WHO: Weekly Epidemiol Rec 72:65\u201372, 1997","journal-title":"Weekly Epidemiol Rec"},{"key":"369694_CR4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.510280331","volume":"28","author":"R Burioni","year":"1998","unstructured":"Burioni R, Plaisant P, Manzin A, Rosa D, Delli Carri V, Bugli F, Solforosi L, Abrignani S, Varaldo PE, Fadda G, Clementi M: Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 28:810\u2013814, 1998","journal-title":"Hepatology"},{"key":"369694_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","volume":"116","author":"M Chen","year":"1999","unstructured":"Chen M, Sallberg M, Sonnerborg A, Weiland O, Mattsson L, Jin L, Birkett A, Peterson D, Milich DR: Limited humoral immunity in hepatitis C virus infection. Gastroenterology 116:135\u2013143, 1999","journal-title":"Gastroenterology"},{"key":"369694_CR6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0140-6736(93)91983-S","volume":"342","author":"DY Chien","year":"1993","unstructured":"Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G: Persistence of HCV despite antibodies to both putative envelope glicoproteins. Lancet 342:933, 1993","journal-title":"Lancet"},{"key":"369694_CR7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0952-7915(95)80099-9","volume":"7","author":"C Rice","year":"1995","unstructured":"Rice C, Walker C: Hepatitis C virus-specific T lymphocytes responses. Curr Opin Immunol 7:532\u2013538, 1995","journal-title":"Curr Opin Immunol"},{"key":"369694_CR8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/hep.1840190205","volume":"19","author":"C Ferrari","year":"1994","unstructured":"Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F: T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286\u2013295, 1994","journal-title":"Hepatology"},{"key":"369694_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","volume":"10","author":"S Cooper","year":"1999","unstructured":"Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P, Walker CM: Analysis of a successful immune response against hepatitis C virus. Immunity 10:439\u2013449, 1999","journal-title":"Immunity"},{"key":"369694_CR10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.510300312","volume":"30","author":"A Cemy","year":"1999","unstructured":"Cemy A, Chisari F: Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology 30:595\u2013601, 1999","journal-title":"Hepatology"},{"key":"369694_CR11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0016-5085(98)70277-X","volume":"115","author":"K Chang","year":"1998","unstructured":"Chang K: The mechanisms of chronicity in hepatitis C virus infection. Gastroenterology 115:1015\u20131018, 1998","journal-title":"Gastroenterology"},{"key":"369694_CR12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","volume":"98","author":"G Missale","year":"1996","unstructured":"Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C: Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98:706\u2013714, 1996","journal-title":"J Clin Invest"},{"key":"369694_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0016-5085(93)90430-K","volume":"104","author":"P Botarelli","year":"1993","unstructured":"Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, Shuster JR, Kuo G, Bonino F, Houghton M, Abrignani S: T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580\u2013587, 1993","journal-title":"Gastroenterology"},{"key":"369694_CR14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","volume":"346","author":"HM Diepolder","year":"1995","unstructured":"Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR: Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006\u20131007, 1995","journal-title":"Lancet"},{"key":"369694_CR15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.510280332","volume":"28","author":"JJ Lasarte","year":"1998","unstructured":"Lasarte JJ, Garcia-Granero M, Lopez A, Casares N, Garcia N, Civeira MP, Borras-Cuesta F, Prieto J: Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology 28:815\u2013822, 1998","journal-title":"Hepatology"},{"key":"369694_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hep.510230102","volume":"23","author":"G Leroux-Roels","year":"1996","unstructured":"Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippe J, Desombere I, Paradijs J, Maertens GA: Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alpha. Hepatology 23:8\u201316, 1996","journal-title":"Hepatology"},{"key":"369694_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00945024","volume":"19","author":"S Abrignani","year":"1997","unstructured":"Abrignani S: Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol 19:47\u201355, 1997","journal-title":"Springer Semin Immunopathol"},{"key":"369694_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.146.1.108","volume":"146","author":"M Betz","year":"1991","unstructured":"Betz M, Fox B: Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146:108\u2013113, 1991","journal-title":"J Immunol"},{"key":"369694_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/cyto.1996.0150","volume":"9","author":"N Ferreri","year":"1997","unstructured":"Ferreri N, Millet I, Askari B, Magnani P, Ruddle N: Lymphotoxin-\u03b1 and TNF regulation in T cell subsets: Differential effects of PGE2. Cytokine 9:157\u2013165, 1997","journal-title":"Cytokine"},{"key":"369694_CR20","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.4049\/jimmunol.121.6.2573","volume":"121","author":"JJ Ellner","year":"1978","unstructured":"Ellner JJ: Suppressor adherent cells in human tuberculosis. J Immunol 121:2573\u20132579, 1978","journal-title":"J Immunol"},{"key":"369694_CR21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4049\/jimmunol.123.4.1639","volume":"123","author":"EA Ottesen","year":"1979","unstructured":"Ottesen EA: Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens. J Immunol 123:1639\u20131644, 1979","journal-title":"J Immunol"},{"key":"369694_CR22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2249.1992.tb06426.x","volume":"87","author":"R Victorino","year":"1992","unstructured":"Victorino R, Maria V, Pinto L: Evidence for prostaglandinproducing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization. Clin Exp Immunol 87:132\u2013137, 1992","journal-title":"Clin Exp Immunol"},{"key":"369694_CR23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM197711032971802","volume":"297","author":"J Goodwin","year":"1977","unstructured":"Goodwin J, Messner R, Bankhurst A, Peake G, Saiki J, Williams R: Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med 297:963\u2013968, 1977","journal-title":"N Engl J Med"},{"key":"369694_CR24","first-page":"197","volume":"11","author":"RM Victorino","year":"1983","unstructured":"Victorino RM: Indomethacin sensitive suppressor cells in Crohn's disease: A possible role in decreased lymphocyte responsiveness. J Clin Lab Immunol 11:197\u2013201, 1983","journal-title":"J Clin Lab Immunol"},{"key":"369694_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-90-2-169","volume":"90","author":"J Goodwin","year":"1979","unstructured":"Goodwin J, Dehoratius R, Israel H, Peake G, Messner R: Suppressor cell function in sarcoidosis. Ann Intern Med 90:169\u2013173, 1979","journal-title":"Ann Intern Med"},{"key":"369694_CR26","first-page":"391","volume":"75","author":"P Foley","year":"1992","unstructured":"Foley P, Kazazi F, Biti R, Sorrell TC, Cunningham AL: HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 75:391\u2013397, 1992","journal-title":"Immunology"},{"key":"369694_CR27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI109186","volume":"62","author":"J Goodwin","year":"1978","unstructured":"Goodwin J, Messner R, Peak G: Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. J Clin Invest 62:753\u2013760, 1978","journal-title":"J Clin Invest"},{"key":"369694_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/infdis\/152.1.171","volume":"152","author":"M Kleinhenz","year":"1985","unstructured":"Kleinhenz M, Ellner J: Immunoregulatory adherent cells in human tuberculosis: Radiation-sensitive antigen-specific suppression by monocytes. J Infect Dis 152:171\u2013176, 1985","journal-title":"J Infect Dis"},{"key":"369694_CR29","first-page":"31","volume":"110","author":"M Kleinhenz","year":"1987","unstructured":"Kleinhenz M, Ellner J: Antigen responsiveness during tuberculosis: Regulatory interactions of T cell subpopulations and adherent cells. J Lab Clin Med 110:31\u201340, 1987","journal-title":"J Lab Clin Med"},{"key":"369694_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.136.1.186","volume":"136","author":"S Kunkel","year":"1986","unstructured":"Kunkel S, Chensue S, Phan S: Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 136:186\u2013192, 1986","journal-title":"J Immunol"},{"key":"369694_CR31","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.150.12.5321","volume":"150","author":"F Snijdewint","year":"1983","unstructured":"Snijdewint F, Kalinski P, Wierenga E, Bos J, Kapsenberg M: Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150:5321\u20135329, 1983","journal-title":"J Immunol"},{"key":"369694_CR32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.130.3.1350","volume":"1330","author":"T Goto","year":"1983","unstructured":"Goto T, Herberman R, Maluish A, Strong D: Cyclic AMP as a mediator of prostaglandin E-induced suppression of human killer cell activity. J Immunol 1330:1350\u20131355, 1983","journal-title":"J Immunol"},{"key":"369694_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI110231","volume":"68","author":"M Kleinhenz","year":"1981","unstructured":"Kleinhenz M, Ellner J, Spagnuolo P, Daniel T: Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. J Clin Invest 68:153\u2013162, 1981","journal-title":"J Clin Invest"},{"issue":"S1","key":"369694_CR34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2893.1999.00006.x","volume":"6","author":"G Pape","year":"1989","unstructured":"Pape G, Gerlach T, Diepolder H, Gr\u00fcner N, Jung M, Santantonio T: Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepatitis 6(S1):36\u201340, 1989","journal-title":"J Viral Hepatitis"},{"key":"369694_CR35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0168-8278(96)80080-8","volume":"25","author":"MU Mondelli","year":"1996","unstructured":"Mondelli MU: Is there a role for immune responses in the pathogenesis in hepatitis C? J Hepatol 25:232\u2013238, 1996","journal-title":"J Hepatol"},{"key":"369694_CR36","first-page":"790","volume":"24","author":"M Lechmann","year":"1996","unstructured":"Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U: T-and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C virus infection and healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 24:790\u2013795, 1996","journal-title":"Hepatology"},{"key":"369694_CR37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/jcm.31.4.936-940.1993","volume":"3","author":"C Ishida","year":"1993","unstructured":"Ishida C, Matsumoto K, Fukada K, Matsushita K, Shiraki H, Maeda Y: Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzymelinked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol 3:936\u2013940, 1993","journal-title":"J Clin Microbiol"},{"key":"369694_CR38","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1128\/jvi.71.8.6011-6019.1997","volume":"71","author":"HM Diepolder","year":"1997","unstructured":"Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, Scholz S, Santantonio T, Houghton M, Southwood S, Sette A, Pape GR: Immundominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71:6011\u20136019, 1997","journal-title":"J Virol"},{"key":"369694_CR39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/978-3-642-46870-4_24","volume":"154","author":"C Ferrari","year":"1998","unstructured":"Ferrari C, Penna A, Bertoletti A, Cavalli A, Missale G, Lamonaca V: Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections. Recent Results Cancer Res 154:330\u2013336, 1998","journal-title":"Recent Results Cancer Res"},{"key":"369694_CR40","first-page":"632","volume":"21","author":"RM Hoffmann","year":"1995","unstructured":"Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, Riethmuller G, Pape GR: Mapping of immunodominant CD4_ T lymphocytes epitope of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21:632\u2013636, 1995","journal-title":"Hepatology"},{"key":"369694_CR41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2893.1999.00161.x","volume":"6","author":"A Hyman","year":"1999","unstructured":"Hyman A, Yim C, Krajden M, Read S, Basinski AS, Wanless I, Levy G, Heathcote J: Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C. J Viral Hepatitis 6:329\u2013336, 1999","journal-title":"J Viral Hepatitis"},{"key":"369694_CR42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.510300224","volume":"30","author":"S Giambartolomei","year":"1999","unstructured":"Giambartolomei S, Artini M, Almerighi C, Moavero SM, Levrero M, Balsano C: Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation. Hepatology 30:510\u2013516, 1999","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017911918332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1017911918332\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017911918332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:16:11Z","timestamp":1753758971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1017911918332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["369694"],"URL":"https:\/\/doi.org\/10.1023\/a:1017911918332","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}